Where is Dobecure located?

Dobecure is headquartered in Madrid, Spain.

Who is the current CEO of Dobecure?

Alfonso Garcia Canamaque of Dobecure.

How many employees does Dobecure have?

As of May 31, 2026, the latest employee count at Dobecure is 1.

Is Dobecure a funded company?

Dobecure is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Dobecure rank among its competitors?

Dobecure ranks 2333rd amongst 2654 active competitors, of which 904 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of Dobecure?

Dobecure's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Immuneel secured the most recent funding round in June, 2026.

Dobecure - 2026 Company Profile, Team & Competitors

Company Details

Developer of therapeutics for ophthalmologic disorder. The therapies based on synthetic inhibitors of fibroblast growth factor are developed for the treatment of age-related macular degeneration, both wet and dry, uveitis, corneal edema and herpetic keratitis, tendinitis, cold sores, otitis, and allergic rhinitis.

Website: dobecure.com
Social
Email ID: *****@dobecure.com

Key Metrics

Founded Year

2017

Location

Madrid, Spain

Stage

Unfunded

Ranked

2333^rd among 2654 active competitors

Employee Count

1 as on May 31, 2026

Similar Companies

Viridian Therapeutics & 288 more

View Dobecure's full profile

Dobecure has not raised any funding rounds yet.

Dobecure's employee count trend

Dobecure has 1 employees as of May 26. Here is Dobecure's employee count trend over the years:

Uncover Dobecure's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Dobecure include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Dobecure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, F-Prime Capital & 17 others	73/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
4th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
5th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Domain Associates, Fidelity Investments & 19 others	72/100
6th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	71/100
7th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
8th	Erasca 2018, San Diego (United States), Public	Developer of small molecule based therapeutics for cancer	$300M	Cormorant Asset Management, Arch Venture Partners ... & 13 others	71/100
9th	Elicio 2012, Cambridge (United States), Public	Developer of vaccines for treating cancer	$47.4M	Dreavent, Livzon Pharmaceutical & 5 others	71/100
10th	Celularity 2016, Warren (United States), Public	Developer of allogeneic cell therapies to treat multiple diseases	$290M	Celgene, Dreyfus Family Office & 8 others	71/100
2333rd	Dobecure 2017, Madrid (Spain), Unfunded	Developer of therapeutics for ophthalmologic disorder	-	-	22/100